Company Filing History:
10 out of 10 
1 out of 787 
1 out of 560 
Years Active: 2002-2008
Title: The Innovations of William M. Canfield
Introduction
William M. Canfield is a notable inventor based in Oklahoma City, OK (US). He has made significant contributions to the field of glycobiology, particularly in the area of lysosomal enzymes. With a total of 13 patents to his name, Canfield's work has had a profound impact on medical research and therapeutic development.
Latest Patents
Among his latest patents, Canfield has developed the GlcNAc phosphotransferase of the lysosomal targeting pathway. This invention provides nucleotide and amino sequences of the enzyme GlcNAc-phosphotransferase, along with methods for producing and purifying this enzyme. Another significant patent involves the expression of lysosomal hydrolase in cells that express pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosaminidase. This invention outlines methods for producing this enzyme in mammalian cells that are deficient in the furin proteolytic enzyme, as well as methods for creating lysosomal hydrolases that contain N-acetylglucosamine-1-phosphate.
Career Highlights
Canfield has worked with prominent organizations such as the Genzyme Glycobiology Research Institute Inc. and Genzyme Corporation. His work in these institutions has allowed him to advance his research and contribute to the development of innovative solutions in glycobiology.
Collaborations
Some of his notable coworkers include Stuart Kornfeld and Mariko Kudo. Their collaborative efforts have further enriched the research landscape in which Canfield operates.
Conclusion
William M. Canfield's contributions to the field of glycobiology through his patents and collaborations highlight his role as a leading inventor. His work continues to influence advancements in medical research and therapeutic applications.